CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-28 | Abdun-Nabi Daniel President & CEO | Shares withheld for taxes | −6,184 | $30.63 | $189K | 223,098 |
| 2017-02-28 | Abdun-Nabi Daniel President & CEO | Grant or award · Employee Stock Option (right to buy) | +78,329 | $30.63 | $2.4M | 78,329 |
| 2017-02-28 | El-Hibri Fuad Chairman | Exercise or conversion | +9,722 | 1,658,795 | ||
| 2017-02-28 | El-Hibri Fuad Chairman | Shares withheld for taxes | −2,659 | $30.63 | $81K | 1,656,136 |
| 2017-02-28 | El-Hibri Fuad Chairman | Grant or award · Restrictive Stock Units | +29,382 | 105,576 | ||
| 2017-02-28 | El-Hibri Fuad Chairman | Exercise or conversion · Restrictive Stock Units | −9,722 | 95,854 | ||
| 2017-02-28 | El-Hibri Fuad Chairman | Grant or award · Employee Stock Option (right to buy) | +58,747 | 58,747 | ||
| 2017-02-27 | Abdun-Nabi Daniel President & CEO | Exercise or conversion | +3,662 | $30.63 | $112K | 192,824 |
| 2017-02-27 | Abdun-Nabi Daniel President & CEO | Shares withheld for taxes | −1,735 | $30.63 | $53K | 191,089 |
| 2017-02-27 | Abdun-Nabi Daniel President & CEO | Shares withheld for taxes | −984 | $30.63 | $30K | 190,105 |
| 2017-02-27 | Abdun-Nabi Daniel President & CEO | Exercise or conversion · Stock Option - (Right to Buy) | −3,662 | 0 | ||
| 2017-01-17 | Bailey Sue Director | Exercise or conversion | +3,157 | $10.64 | $34K | 38,975 |
| 2017-01-17 | Bailey Sue Director | Sale | −3,157 | $29.78 | $94K | 35,818 |
| 2017-01-17 | Bailey Sue Director | Exercise or conversion | +3,157 | $14.71 | $46K | 38,975 |
| 2017-01-17 | Bailey Sue Director | Sale | −3,157 | $29.78 | $94K | 35,818 |
| 2017-01-17 | Bailey Sue Director | Exercise or conversion | +3,157 | $20.08 | $63K | 38,975 |
| 2017-01-17 | Bailey Sue Director | Sale | −3,157 | $29.78 | $94K | 35,818 |
| 2017-01-17 | Bailey Sue Director | Exercise or conversion | +4,735 | $13.37 | $63K | 40,553 |
| 2017-01-17 | Bailey Sue Director | Sale | −4,735 | $29.78 | $141K | 35,818 |
| 2017-01-17 | Bailey Sue Director | Exercise or conversion | +3,157 | $13.00 | $41K | 38,975 |
Page 47 of 65 · 1,282 trades